David B Geffen

Summary

Affiliation: Ben-Gurion University of the Negev
Country: Israel

Publications

  1. ncbi Ipsilateral breast carcinoma following treatment for primary breast lymphoma
    David B Geffen
    Department of Oncology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Onkologie 30:134-6. 2007
  2. ncbi The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy
    D B Geffen
    Department of Oncology, Ben Gurion University of the Negev, Beer Sheva
    Ann Oncol 22:2381-6. 2011
  3. ncbi Stage I breast cancer in a regional oncology practice in Israel 2002-2006: clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients
    D B Geffen
    Department of Oncology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Breast 18:316-21. 2009
  4. ncbi The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial
    Tamar Safra
    Department of Oncology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Oncology 81:298-305. 2011
  5. ncbi Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test
    Svetlana Prokasheva
    Department of Social Work, Ben Gurion University of the Negev, Beer Sheva, Israel
    J Psychosoc Oncol 29:499-514. 2011
  6. ncbi Disseminated intravascular coagulation at presentation of advanced gastric cancer
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr Med Assoc J 8:853-5. 2006
  7. ncbi Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneys
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center, Beer Sheva, Israel
    Leuk Lymphoma 45:819-20. 2004
  8. ncbi Metastatic tumors to the jaws: a report of eight new cases
    Lisa Bodner
    Department of Oral and Maxillofacial Surgery, Soroka University Medical Center, Beer Sheva, Israel
    Med Oral Patol Oral Cir Bucal 11:E132-5. 2006
  9. ncbi [Cancer-related lymphedema in Israel]
    Avi Shimony
    Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev
    Harefuah 147:624-7, 661. 2008
  10. ncbi Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature
    Margarita Tokar
    Department of Oncology, Ben Gurion University of the Egev, Beer Sheva, Israel
    Onkologie 29:30-2. 2006

Collaborators

Detail Information

Publications14

  1. ncbi Ipsilateral breast carcinoma following treatment for primary breast lymphoma
    David B Geffen
    Department of Oncology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Onkologie 30:134-6. 2007
    ..The breast is an unusual site for primary non-Hodgkin's lymphoma. Carcinoma in the same breast after treatment for lymphoma poses therapeutic challenges, but there is only 1 case report in Japanese, which describes this occurrence...
  2. ncbi The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy
    D B Geffen
    Department of Oncology, Ben Gurion University of the Negev, Beer Sheva
    Ann Oncol 22:2381-6. 2011
    ..There is limited published data on the impact of the assay on clinical practice, particularly in the context of a single practice with a unified treatment policy...
  3. ncbi Stage I breast cancer in a regional oncology practice in Israel 2002-2006: clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients
    D B Geffen
    Department of Oncology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Breast 18:316-21. 2009
    ..8%. Individualized risk estimation by genetic analysis may further decrease the use of chemotherapy in stage I patients. Breast cancer screening may provide an opportunity to identify cancer prone families...
  4. ncbi The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial
    Tamar Safra
    Department of Oncology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Oncology 81:298-305. 2011
    ..ObjECTIVE: This study reports the efficacy and safety of zoledronic acid (ZOL) in preventing bone loss in postmenopausal patients receiving an aromatase inhibitor (AI) following tamoxifen...
  5. ncbi Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test
    Svetlana Prokasheva
    Department of Social Work, Ben Gurion University of the Negev, Beer Sheva, Israel
    J Psychosoc Oncol 29:499-514. 2011
    ..The Doors and People Test is a sensitive measure of memory deficits that is feasible for use with clinical populations of breast cancer patients in order to monitor changes in cognitive function...
  6. ncbi Disseminated intravascular coagulation at presentation of advanced gastric cancer
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr Med Assoc J 8:853-5. 2006
    ..Effective chemotherapy of the underlying malignancy may be the only way to control acute DIC...
  7. ncbi Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneys
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center, Beer Sheva, Israel
    Leuk Lymphoma 45:819-20. 2004
    ..The patients renal function improved on therapy, with no need for hemodialysis and there were no significant toxicities. Rituximab may be used as a treatment option for NHL patients with impaired renal function...
  8. ncbi Metastatic tumors to the jaws: a report of eight new cases
    Lisa Bodner
    Department of Oral and Maxillofacial Surgery, Soroka University Medical Center, Beer Sheva, Israel
    Med Oral Patol Oral Cir Bucal 11:E132-5. 2006
    ..The purpose of the article is to present 8 new cases of metastatic tumors occurring in the jawbones, their clinical features , diagnostic workup and management...
  9. ncbi [Cancer-related lymphedema in Israel]
    Avi Shimony
    Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev
    Harefuah 147:624-7, 661. 2008
    ..In addition, some insights were provided regarding lymphedema treatment in Israel. This review aims to improve the awareness and knowledge of physicians and other health care professionals on this treatable but often forgotten condition...
  10. ncbi Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature
    Margarita Tokar
    Department of Oncology, Ben Gurion University of the Egev, Beer Sheva, Israel
    Onkologie 29:30-2. 2006
    ..We report on a patient with squamous cell anal carcinoma and liver metastases, who underwent multimodal treatment for cure, consisting of repeated partial hepatectomy in combination with chemoradiotherapy...
  11. ncbi Post-traumatic stress disorder and quality of life in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma in Israel
    David B Geffen
    Department of Oncology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 44:1925-9. 2003
    ..Psychological interventions in the early stages of treatment or follow-up may help reduce the morbidity from PTSD and improve quality of life...
  12. ncbi New drugs for the treatment of cancer, 1990-2001
    David B Geffen
    Department of Oncology, Soroka University Medical Center and Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr Med Assoc J 4:1124-31. 2002
    ....
  13. ncbi Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer
    Konstantin Lavrenkov
    Department of Oncology, Soroka University Medical Center, Beer Sheva, Israel
    Isr Med Assoc J 4:176-7. 2002
    ..Several new agents have been approved for the treatment of breast cancer in the metastatic setting, among which is the new non-steroidal aromatase inhibitor, anastrozole, introduced for clinical use in Israel in March 1997...
  14. ncbi Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study
    Ido Wolf
    The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel
    Cancer 112:731-6. 2008
    ..To the authors' knowledge, the association between the RS and clinicopathologic characteristics has been studied in randomized and case-control trials, but not in the general population...